Adiponectin is considered to have anti-diabetic and anti-inflammatory effects; therefore, it is reasonable to presume that patients with T2DM who are obese exhibit more severe insulin resistance status than patients with T2DM who have normal BMI. The gene discussed is ADIPOQ; the disease is type 2 diabetes mellitus.